Aprea Therapeutics Inc (APRE)

NASDAQ
4.26
-0.08(-1.84%)
After Hours
4.25
-0.01(-0.23%)
- Real-time Data
  • Volume:
    404,437
  • Bid/Ask:
    4.25/4.26
  • Day's Range:
    4.15 - 4.37

APRE Overview

Prev. Close
4.34
Day's Range
4.15 - 4.37
Revenue
-
Open
4.34
52 wk Range
4.15 - 41.12
EPS
-2.53
Volume
404,437
Market Cap
91.95M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
1,030,105
P/E Ratio
-
Beta
-
1-Year Change
-87.1%
Shares Outstanding
21,186,827
Next Earnings Date
May 14, 2021
What is your sentiment on Aprea Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Aprea Therapeutics Inc News

Aprea Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuySellStrong SellStrong SellStrong Sell
SummaryStrong BuyNeutralStrong SellStrong SellStrong Sell

Aprea Therapeutics Inc Company Profile

Aprea Therapeutics Inc Company Profile

Employees
17

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its lead product candidate, APR-246, is a small molecule p53 reactivator that is being developed for hematologic malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). APR-246 product candidate is designed to be administered intravenously and forms the active moiety, 2-methylene-quinuclidin-3-one (MQ), under physiological conditions. Its second product candidate, APR-548, is a p53 reactivator. APR-548 is being developed in an oral dosage form.

Read More
  • we are currently in wave C of Elliott wave. Support at $4.77 and resistance $5.95
    0
    • Sold Apr 21 $5 puts $.50 for a total gain of $1,250 let's see if they expire worthless?
      0
      • back to 20-40 range?
        0
        • Kinda hope so !!!
          0
        • Gary Vosganian still long?
          0
      • This should return to mid teens soon
        0
        • I am afraid, I think they will take it below $5.
          0
      • just a $h it
        0
        • company sure did *****all there investors...only people that came out on top was the company and there lavish lifestyle there living
          2
          • this will go back up to $10 within the next couple months don't panic. The tests still showed positive results, just not considered statistically significant.
            3
            • Oh my what happen? almost bankrupt
              0
            • Chester Mendoza yes, I bought more shares at 5.52 (average = 8.03)
              0
            • It wasn't good news but wasn't an end either. Think this will rally back to mid teens in the near future.
              0
          • what happened
            0
            • results of phase 3
              0
          • when are the results coming out on there phase 3 trials
            0
            • must be worst result
              0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.